Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Topical versus oral corticosteroids in moderate drug reaction with eosinophilia and systemic symptoms: A multicenter randomized clinical trial.
Ingen-Housz-Oro S, Guichard E, Milpied B, Bensaid B, Collet E, Barbaud A, Le Duff F, Tétart F, Soria A, Machet L, Descamps V, Monestier S, Pasteur J, Morice C, Chaby G, Colin A, Grégoire L, Allanore L, Giraudeau B, Chosidow O. Ingen-Housz-Oro S, et al. Among authors: descamps v. J Am Acad Dermatol. 2024 Sep;91(3):544-547. doi: 10.1016/j.jaad.2024.04.077. Epub 2024 May 14. J Am Acad Dermatol. 2024. PMID: 38754628 Free article. Clinical Trial. No abstract available.
Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients.
Cohen E, Lheure C, Ingen-Housz-Oro S, Hotz C, Bettuzzi T, Chasset F, Descamps V, Deschamps L, Mahevas M, Terrier B, Sohier P, Guegan S, Kramkimel N, Darbord D, Chanal J, Oulès B, Aractingi S, Seta V, Dupin N. Cohen E, et al. Among authors: descamps v. Eur J Dermatol. 2023 Dec 1;33(6):680-685. doi: 10.1684/ejd.2023.4584. Eur J Dermatol. 2023. PMID: 38465550
French national protocol for diagnosis and management of epidermal necrolysis in adults (Stevens-Johnson syndrome and toxic epidermal necrolysis).
Ingen-Housz-Oro S, Matei I, Gaillet A, Gueudry J, Zaghbib K, Assier H, Hua C, Bensaid B, Colin A, Ouedraogo R, Redlich J, Courtois E, Chazelas K, Sbidian E, Nakad L, Bequignon E, Terkmane N, Gaultier F, Schlemmer F, Do-Pham G, Barbaud A, Lebrun-Vignes B, Hoffmann C, Mahé PJ, Le Floch R, Bernier C, Vabres B, Milpied B, Delcampe A, Tétart F, Tauber M, Staumont-Sallé D, Dezoteux F, Descamps V, Misery L, Bursztejn AC, Dereure O, Amazan E, Le Bidre E, Le Pallec S, Lagier C, Laroche A, Ferrat E, Wolkenstein P, de Prost N; French National Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL. Ingen-Housz-Oro S, et al. Among authors: descamps v. Ann Dermatol Venereol. 2024 Jun;151(2):103282. doi: 10.1016/j.annder.2024.103282. Epub 2024 May 28. Ann Dermatol Venereol. 2024. PMID: 38810539 Free article. No abstract available.
[Item 110 - UE 4 Autoimmune bullous dermatosis].
CEDEF. CEDEF. Ann Dermatol Venereol. 2015 Jun;142 Suppl 2:S42-50. doi: 10.1016/j.annder.2015.02.013. Epub 2015 Apr 3. Ann Dermatol Venereol. 2015. PMID: 25846466 French. No abstract available.
[Item 113 - UE 4 Pruritus].
CEDEF. CEDEF. Ann Dermatol Venereol. 2015 Jun;142 Suppl 2:S67-72. doi: 10.1016/j.annder.2015.02.016. Epub 2015 Apr 4. Ann Dermatol Venereol. 2015. PMID: 25846468 French. No abstract available.
383 results